Soviets Took Probiotics to the Next Level, Say Researchers at U.S. Probiotic Firm

Soviets Took Probiotics to the Next Level, Say Researchers at U.S. Probiotic
Firm

BOULDER, Colo., Jan. 15 /PRNewswire-FirstCall/ -- During the Cold War Era
of the 1960s, Russian researchers were looking for ways to support the immune
system in conditions running the gamut from cancer to bio-warfare agents.
Eastern Europeans, with a cultural love of fermented milk products, logically
looked to probiotics, or lactobacillus, for immune support because it was
safe, cheap and effective.
A Bulgarian researcher and medical doctor, Dr. Ivan Bogdanov, researched
lactobacillus bacteria in the 1960s. Bogdanov believed that specific strains
of probiotics could have anti-tumor properties.
The doctor's research team injected mice with a sarcoma cancer, then
administered a crude mixture of cell fragments from a strain of Lactobacillus
delbrukii. Bogdanov observed that the cancer disappeared within a few days.
Subsequently, researchers attempted to re-grow cancer in the same mice, but
without success -- the mice seemed immune to the cancer cells.
In the 1970s, a Soviet-owned biotech company, Enzymes Ltd., worked on
developing products for protection against bio-warfare agents such as anthrax.
The researchers discovered that not only did probiotic cell fragments support
healthy immune function -- they offered protection from radiation sickness and
cell damage.
"We used a lactobacillus cell fragments after Chernobyl, conducting
experimental work on animals exposed to radiation, then later on humans," said
Dr. Luba Shynkarenko, former dean of the Institute of Biotechnology at the
National Technical University in Kiev, Ukraine. Shynkarenko also worked for
Enzymes, Ltd. in 1986 at the time of the Chernobyl accident.
"We found the cell fragments provided protection from radiation cell
damage, and also anti-mutagenic activity, which meant the genetic material was
protected from radiation. The main damage of radiation is destruction of the
bone marrow cells and genetic damage that causes cellular mutation," she said.
American-made Del-Immune V is the first probiotic cell-fragment immune
support products available in the U.S. market. This is a direct descendant of
Shynkarenko's Chernobyl research, and is gathering a broad fan-base that
includes doctors and health practitioners in all 50 states.
"I find this product of significant value for treating patients with
chronic disease, where someone has been ill for a period of time with
infectious agents and micro-organisms. It has a restorative effect on the
immune system after damage from malnutrition, stress and infection," said Dr.
Roger Mazlen of Roslyn, N.Y. Dr. Mazlen added that he has successfully used
the product in over 500 patients with no contra-indications or side effects.
Information is available at http://www.delimmune.com.

Contact:

Pamela Sichel
(303) 530-7761

This release was issued through eReleases(TM). For more information,
visit http://www.ereleases.com.
SOURCE Pure Research Products

Pamela Sichel of Pure Research Products, +1-303-530-7761